TGFB1 and colorectal carcinoma: Blockade of the TGFβ signaling pathway has emergedfrom preclinicalstudies as a potential treatment to enhance the efficacy of immunecheckpoint inhibition in advanced colorectal cancer (CRC) and severalother types of cancer.